All News

cardiac2.jpg (keep)

Higher Cardiovascular Risks with Systemic Lupus Erythematosus

d Jack Cush, MD

The Journal of the American College of Cardiology has published the results of a study showing that patients with systemic lupus erythematosus (SLE) have an increased risk of heart failure (HF) and other long-term cardiovascular outcomes. 

Read Article
640px-Fluorescent_uric_acid.JPG

Uric Acid: A Major Player in the Metabolic Syndrome

d Jack Cush, MD

An open source, free read from the European Journal of Internal Medicine discusses how uric acid has evolved from the toxic cause of gout and nephrolithiasis and evolved, by way of science, into a pleiotropic recidivist in the evolution of obesity, diabetes, insulin resistance, renal disease, hypertension, fatty liver, and cardiovascular disease.

Read Article
RheumNow Podcast square

RheumNow Podcast – Uppers and Downers

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Read Article
New download available! Osteoarthritis vs. Rheumatoid Arthritis https://t.co/qvVEcKqNAM https://t.co/3f8sRSgyQo

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Higher Cardiovascular Risks with Systemic Lupus Erythematosus The Journal of the American College of Cardiology has published a study showing that patients with SLE have an increased risk of HF and other long-term cardiovascular outcomes. https://t.co/g07tIP5jBx https://t.co/3fHzgrJjUi

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Uric Acid: A Major Player in the Metabolic Syndrome Uric acid, and hyperuricemia, has been closely linked with may of the components of the metabolic syndrome, which is largely a consequence of excessive fat storage. https://t.co/ObQ0LURodb https://t.co/HT35ODnFkn

Links:

Dr. John Cush RheumNow ( View Tweet)
Risk factors for Kawasaki disease in Taiwan compared 4197 KD pts to controls. KD was more common in Males (OR 1.47), older mothers (>35 y; OR, 1.18), and in multivariable analysis, maternal ankylosing spondylitis (OR 2.02). https://t.co/4qbddaYkqY

Links:

Dr. John Cush RheumNow ( View Tweet)

Real world comparision of baricitinib (n 138) and tofacitinib (n 156) in #RA patients shows at wk 24, BARI out performed TOFA - CDAI remission (40.4 vs 28.3%) and CDAI LDA (81.6 vs 69.3%); safety signals were equal between groups. https://t.co/0quNNGB18K

Links:

Dr. John Cush RheumNow ( View Tweet)

Top April Tweet: Serious problem! Pulmonologists believe that MTX causes and/or worsens ILD. MTX causes hypersensitivity pneumonitis, not ILD. RA, lupus DM, PSS cause ILD and may need MTX to manage their disease. Research, look at this paper to start. https://t.co/8812FN2b8Q https://t.co/m9lCkYBnyb

Links:

Dr. John Cush RheumNow ( View Tweet)
News Features: Seven Year Delay in Diagnosing Spondyloarthritis A large patient cohort study suggests that the mean diagnostic delay (DD) in European axSpA patients is 7.4 years, moreso in women and younger patients. https://t.co/m2yIkrwcFA https://t.co/N7Z0BUeBUN

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Psoriatic Pregnancies Pose Risks to the Mother, Not Child A metanalysis of pregnancy outcomes in women with psoriasis and psoriatic arthritis finds an excess risk of adverse maternal events, but not adverse neonatal events. https://t.co/kZE2yLEvm7 https://t.co/OYQhM10csl

Links:

Dr. John Cush RheumNow ( View Tweet)
Have you had the chance to listen to last week's podcast? We have news of Uppers and Downers. Hear about vaccine success, CKD gout prophylaxis, TOFA in AS & too much IL-17 inhib can be a problem https://t.co/kt63YrQ0Sw Listen iTunes> https://t.co/FHJv01AAbC or Android SoundCloud https://t.co/jbeNhYUdqz

Links:

Dr. John Cush RheumNow ( View Tweet)
Tomorrow--join us for Tuesday Night Rheumatology focusing on Psoriatic Arthritis with Dr. Eric Ruderman, Melodie Young, and Dr. Alexis Ogdie Beatty. https://t.co/9S3dKnZ9to https://t.co/dPmw9eklQz

Links:

Dr. John Cush RheumNow ( View Tweet)
Nested case–control study from the Danish (DANBIO) Register and 8019 Psoriatic arthritis patients shows that pain alone does not influence mortality risk; however steroid and comorbidities do! https://t.co/74haeSXwXn

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: ACR Updates COVID-19 Vaccine Guidance- April 2021 https://t.co/BgrFxCgjRw

Links:

Dr. John Cush RheumNow ( View Tweet)

Tuesday Night Rheumatology from April 20 #RNL21: Update - Global Rheumatology Alliance Registry https://t.co/QQY80evw00 https://t.co/jkBmAP09xU

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast up! Uppers and Downers. https://t.co/kt63YryptW

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Predictors of Methotrexate Toxicity https://t.co/HjszwdaxVR

Links:

Dr. John Cush RheumNow ( View Tweet)

Did you miss this week’s Tuesday Night Rheumatology? Listen to the playback. https://t.co/yTYkeSY7my

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast is Up! – with news of Uppers and Downers. Read about Vaccine success, CKD gout prophylaxis, TOFA in AS & too much IL-17 inhib can be a problem https://t.co/kt63YrQ0Sw Listen iTunes> https://t.co/FHJv01AAbC or Android SoundCloud>>https://t.co/IyYvjkWUc1

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×